ArticleTherapeutic advances in drug safety2022

A case report of drug-induced liver injury due to the infliximab biosimilar CT-P13 on switching from original infliximab in a patient with Crohn's disease.

Shin Kashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.